66 items
Within seconds of the screening, the blinq™ device calculates a binocularity score based on foveal alignment and provides a “pass” or “refer” result to the clinician. Credt: Andrew Schuman, M.D.

Vision screening device improves detection of “lazy eye”

June 3, 2020

The NEI has funded development of a handheld pediatric vision scanner that easily and accurately screens for amblyopia, or “lazy eye.” The device could facilitate earlier identification of children who need vision-saving treatment.
Krystel Huxlin with patient in laboratory

'Time is vision' after a stroke

May 27, 2020

A person who has a stroke that causes vision loss is often told there is nothing they can do to improve or regain the vision they have lost. But research from the University of Rochester may offer hope to stroke patients in regaining vision.
Fundus photograph of age-related macular degeneration showing drusen.

Pace of eye disease over two years predicts long-term outcome

May 18, 2020

Progression along an age-related macular degeneration (AMD) severity scale over two years predicts the likelihood of developing late-stage disease five years later.
Results from an earlier clinical trial confirmed the benefit of using Avastin over laser therapy for treating the most severe cases of ROP, which occur in a region of the retina known as posterior zone 1, as shown.

Very low-dose Avastin effective for preventing blindness in preterm infants

April 23, 2020

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.
Vegetables and fish on kitchen counter

Diet may help preserve cognitive function

April 14, 2020

According to a recent analysis of data from two major eye disease studies, adherence to the Mediterranean diet – high in vegetables, whole grains, fish, and olive oil – correlates with higher cognitive function.

Four in 10 US Adults Are at High Risk for Vision Loss

March 12, 2020

In 2017, approximately 93 million US adults aged 18 years or older, or about 4 in 10, were at high risk for vision loss, according to a new study published in JAMA Ophthalmology.
A fundus image shows an eye with aggressive posterior retinopathy of prematurity (AP-ROP). The i-ROP DL deep learning system quantified the dilation and tortuosity of the retinal vessels, which both occur to a high degree in AP-ROP.

AI may help spot newborns at risk for most severe form of blinding disease

March 4, 2020

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.
Patient undergoes and eye exam. Courtesy National Eye Institute.

For Aging Patients, One Missed Doctor’s Visit Can Lead to Vision Loss

February 6, 2020

Missing a single ophthalmology appointment over a two-year period was associated with decreased visual acuity for patients with macular degeneration according to a new Penn Medicine study.
Man reading a book

Reward improves visual perceptual learning — but only after people sleep

January 17, 2020

A new study from Brown researchers finds that rewards improve performance on a visual perceptual task only if participants sleep after training.
Blood cells are converted into induced pluripotent stem cells, which are them made into retinal pigment epithelial cells (RPE).

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

December 16, 2019

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.